![]() |
市場調查報告書
商品編碼
1476395
2030 年嗜好大麻市場預測:按產品、管理、化合物、應用、最終用戶和地區進行的全球分析Recreational Cannabis Market Forecasts to 2030 - Global Analysis By Product (Transdermal Patches, Concentrates and Other Products), Administration (Topical, Rectal and Inhalation), Compound, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球嗜好大麻市場規模為 19.3 億美元,預計預測期內複合年成長率為 8.30%,到 2030 年將達到 33.7 億美元。
嗜好大麻是指為了愉悅和放鬆而使用大麻產品的非藥用。它已在世界各地合法化,允許成年人出於娛樂目的購買和消費大麻。使用者通常會尋求精神活性效果,例如欣快感、放鬆和增強的感覺。它有多種形式,包括乾燥花、食用品、濃縮液和酊劑,具有不同的功效等級和食用方式。
美國智庫皮尤研究中心的一項調查顯示,88%的美國成年人支持大麻合法化。具體來說,59%的人支持醫療和娛樂目的合法化,30%支持僅醫療目的合法化。
合法化和監管
合法化和監管是嗜好大麻市場的關鍵驅動力,為種植、分銷和消費提供了框架。合法化消除了與大麻相關的恥辱和犯罪行為,並培養了一個確保產品安全和品質的受監管市場。法規制定了功效、標籤和包裝標準,以保護消費者健康並促進負責任的使用。此外,它還創造課稅機會,為政府創造收入,並為公共措施提供資金來源。這樣的框架也將促進對大麻的醫療和治療潛力的研究,進一步擴大市場。
課稅
嗜好大麻市場的課稅限制是指徵收過高的稅收,阻礙該行業的成長和生存。對大麻產品徵收高稅將導致價格欺詐,並促使消費者重返非法市場。這不僅違背了監管和安全等合法化的目標,也限制了政府的稅收潛力。此外,過度課稅可能會阻礙小型企業和企業家,造成進入壁壘,並有利於大公司。找到課稅平衡對於培育競爭性和永續的嗜好市場同時確保遵守監管標準至關重要。
大麻種植
嗜好大麻市場是大麻種植的巨大機會。隨著許多地區的合法化,需求激增,為高品質大麻產品創造了強勁的市場。種植者可以利用這一點,生產適合消費者偏好的菌株,例如放鬆、創造力或特定的藥用功效。此外,水耕和有機栽培等創新栽培技術可以使產品脫穎而出並吸引挑剔的消費者。利用高效、永續種植方法的技術將進一步提高這個快速成長的市場的盈利。
社會恥辱
嗜好大麻市場的社會恥辱威脅源自於對大麻使用根深蒂固的社會觀念和偏見。儘管在許多地方已經合法化,但負面的刻板印象仍然存在,並導致使用者受到污名化。這種恥辱表現在許多方面,包括就業和住房方面的歧視、社會排斥和負面標籤。這種態度阻止個人尋求幫助或獲得合法大麻產品,從而使邊緣化循環永久化。應對這項威脅需要廣泛的教育、消除污名化的努力以及旨在促進社會對大麻使用的理解和接受的政策。
COVID-19 的爆發在多個方面對嗜好大麻市場產生了重大影響。最初,藥局面臨關閉和限制,供應鏈中斷並減少人流。但隨著封鎖措施的放鬆,許多地區的大麻銷售飆升,因為人們尋求緩解壓力和替代娛樂。此外,向線上銷售和交付服務的轉變加速,反映了消費行為的變化。儘管存在這些波動,監管變化和經濟不確定性仍影響了該行業的投資和擴張計劃。總體而言,COVID-19 凸顯了嗜好大麻市場的彈性,同時凸顯了適應和創新以應對不確定時期的必要性。
錠劑市場預計將在預測期內成為最大的市場
嗜好大麻市場中錠劑市場的成長歸因於消費者可以輕鬆服用藥物而不引起注意的便利性和謹慎性。此外,技術的進步促進了精確劑量和控制釋放製劑的發展,吸引了尋求可預測和一致效果的消費者。此外,注重健康的消費趨勢正在推動對大麻替代方法的需求,例如提供非吸煙選擇的錠劑。此外,監管變化和日益合法化擴大了大麻產品(包括錠劑)的供應,促進了市場成長。
個人護理產業預計在預測期內複合年成長率最高
個人護理產業的成長是由於消費者越來越意識到含有大麻的個人保健產品(如乳液、香膏和沐浴炸彈)的潛在治療功效。這些產品受到追捧,因為據報道它們可以緩解疼痛、減少發炎並提供放鬆效果。此外,隨著合法化的蔓延,對 CBD 等非精神活性大麻衍生物的需求激增。此外,社會對大麻的接受度不斷提高,導致消費者偏好轉向天然和有機成分,進一步增加了大麻個人保健產品的吸引力。
北美嗜好大麻市場的成長是由態度轉變、合法化努力和經濟潛力共同推動的。隨著美國和加拿大的幾個州將嗜好大麻的使用合法化,該市場經歷了快速成長。這種擴張導致投資增加、創造就業機會和稅收增加。此外,消費者對自然和整體療法的偏好的變化正在推動對大麻產品的需求。不斷變化的監管環境和種植技術的進步也促進了市場的成長軌跡。隨著企業家和消費者都接受大麻提供的機會和好處,北美嗜好大麻市場繼續蓬勃發展。
由於人們對大麻使用的態度不斷變化以及合法化努力不斷加大,亞太地區嗜好大麻市場的成長尤其迅速。澳洲、紐西蘭和東南亞部分地區等國家對休閒大麻的接受度正在提高,導致市場快速成長。此外,該地區人口眾多,顯示嗜好大麻產品擁有龐大的消費群。此外,隨著越來越多的國家尋求監管改革和非犯罪化,投資者越來越被該地區的新興市場潛力所吸引。大麻相關產品的供應不斷擴大以及對替代健康解決方案的需求不斷增加將進一步推動這種成長。
According to Stratistics MRC, the Global Recreational Cannabis Market is accounted for $1.93 billion in 2023 and is expected to reach $3.37 billion by 2030 growing at a CAGR of 8.30% during the forecast period. Recreational cannabis refers to the non-medicinal use of cannabis products for enjoyment or relaxation purposes. It's legalized in various regions worldwide, allowing adults to purchase and consume cannabis for recreational purposes. Users typically seek its psychoactive effects, such as euphoria, relaxation, and heightened sensory experiences. Different forms are available, including dried flowers, edibles, concentrates, and tinctures, offering various potency levels and consumption methods.
According to a survey conducted by the Pew Research Center, a US-based think tank, a substantial 88% of U.S. adults expressed a preference for the legalization of marijuana. Specifically, 59% advocate for its legalization for both medical and recreational purposes, while 30% support its legalization solely for medical use.
Legalization and regulation
Legalization and regulation are pivotal drivers of the recreational cannabis market, providing a framework for its cultivation, distribution, and consumption. Legalization removes the stigma and criminality associated with cannabis, fostering a regulated market that ensures product safety and quality. Regulation sets standards for potency, labeling, and packaging, safeguarding consumer health and promoting responsible use. Moreover, it creates opportunities for taxation, generates revenue for governments, and funds public initiatives. This framework also facilitates research into cannabis's medical and therapeutic potential, further expanding its market.
Taxation
Taxation restraint in the recreational cannabis market refers to the imposition of excessive taxes that hinder the growth and viability of the industry. High taxes on cannabis products can lead to inflated prices, driving consumers back to the illegal market. This not only undermines the objectives of legalization, such as regulation and safety, but also limits the tax revenue potential for governments. Moreover, excessive taxation can stifle small businesses and entrepreneurs, creating barriers to entry and favoring larger corporations. Finding a balance in taxation is crucial for fostering a competitive and sustainable recreational cannabis market while ensuring compliance with regulatory standards.
Cannabis cultivation
The recreational cannabis market presents a significant opportunity for cannabis cultivation. With the legalization in many regions, demand has surged, creating a robust market for high-quality cannabis products. Cultivators can capitalize on this by producing strains tailored to consumer preferences, whether it's for relaxation, creativity, or specific medical benefits. Additionally, innovative cultivation techniques, such as hydroponics or organic farming, can differentiate products and attract discerning consumers. Leveraging technology for efficient and sustainable cultivation methods further enhances profitability in this burgeoning market.
Social stigma
The social stigma threat of the recreational cannabis market stems from deeply ingrained societal perceptions and biases surrounding cannabis use. Despite its legalization in many places, negative stereotypes persist, leading to the stigmatization of users. This stigma can manifest in various forms, such as discrimination in employment or housing, social ostracization, and negative labeling. Such attitudes can hinder individuals from seeking help or accessing legitimate cannabis products, perpetuating a cycle of marginalization. Addressing this threat requires widespread education, destigmatization efforts, and policies aimed at promoting understanding and acceptance of cannabis use within society.
The COVID-19 pandemic significantly impacted the recreational cannabis market in several ways. Initially, dispensaries faced closures and restrictions, disrupting supply chains and reducing foot traffic. However, as lockdown measures eased, many regions witnessed a surge in cannabis sales as people sought stress relief and alternative forms of recreation. Additionally, the shift towards online sales and delivery services accelerated, reflecting changing consumer behaviours. Despite these fluctuations, regulatory changes and economic uncertainties affected investments and expansion plans in the industry. Overall, COVID-19 underscored the resilience of the recreational cannabis market while highlighting the need for adaptability and innovation in navigating uncertain times.
The tablets segment is expected to be the largest during the forecast period
The growth of the tablet segment in the recreational cannabis market can be attributed to their convenience and discretion, allowing consumers to easily dose themselves without drawing attention. Additionally, advancements in technology have led to the development of precise dosing and controlled-release formulations, appealing to consumers seeking predictable and consistent effects. Moreover, the trend towards health-conscious consumption has driven demand for alternative methods of cannabis consumption, such as tablets, which offer a smoke-free option. Furthermore, regulatory changes and increasing legalization have expanded the availability of cannabis products, including tablets, driving market growth.
The personal care segment is expected to have the highest CAGR during the forecast period
The growth of the personal care segment can be attributed to an increasing awareness among consumers about the potential therapeutic benefits of cannabis-infused personal care products such as lotions, balms, and bath bombs. These products are being sought after for their reported ability to alleviate pain, reduce inflammation, and provide relaxation. Also, as legalization spreads, there's a burgeoning demand for non-psychoactive cannabis derivatives like CBD, which are often incorporated into personal care items for their purported skin-soothing and anti-inflammatory properties. Additionally, the evolving social acceptance of cannabis has led to a shift in consumer preferences towards natural and organic ingredients, further boosting the appeal of cannabis-infused personal care products.
The growth of the recreational cannabis market in North America has been fueled by a combination of changing attitudes, legalization efforts, and economic potential. With several states in the U.S. and Canada legalizing recreational use, the market has experienced exponential growth. This expansion has led to increased investment, job creation, and tax revenue. Additionally, a shift in consumer preferences towards natural and holistic remedies has driven demand for cannabis products. The evolving regulatory landscape and advancements in cultivation techniques have also contributed to the market's growth trajectory. North America's recreational cannabis market continues to flourish as both entrepreneurs and consumers embrace the opportunities and benefits it offers.
The Asia-Pacific region has seen a notable surge in the recreational cannabis market due to evolving attitudes toward cannabis use and increasing legalization efforts. Countries like Australia, New Zealand, and parts of Southeast Asia are witnessing a growing acceptance of cannabis for leisure purposes, leading to a burgeoning market. Additionally, the region's large population presents a significant consumer base for recreational cannabis products. Moreover, as more nations explore regulatory reforms and decriminalization, investors are increasingly drawn to the potential of this emerging market in the region. This growth is further fueled by the expanding availability of cannabis-related products and the rising demand for alternative wellness solutions.
Key players in the market
Some of the key players in Recreational Cannabis market include 22nd Century Group, Acreage Holdings, Aurora Cannabis Inc., Cannabis Science Inc., Canopy Growth Corporation, Cresco Labs, Front Ventures , HEXO Corp, INDIVA, Medical Marijuana, Inc., Organigrams Holding Inc., Perrigo, PharmaCann Inc., STENOCARE A/S , TerrAscend Corp., The Cronos Group, Tilray Inc., Trulieve, Village Farms International Inc and VIVO Cannabis Inc.
In March 2024, Aurora Cannabis Inc. - The Canadian based leading global medical cannabis company, together with subsidiary company, MedReleaf Australia, have announced the availability of medical cannabis pastilles for doctors to prescribe to patients in Australia. The novel product is produced by Aurora and distributed by MedReleaf Australia, a leading distributor of medical cannabis products with the number two position in the Australian market.
In March 2024, Trulieve Cannabis Corp, a leading and top-performing cannabis company in the U.S., announced the opening of a new medical cannabis dispensary in Cocoa Beach, Florida. The new location will carry a wide variety of popular products including Trulieve's portfolio of in-house brands such as Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One, Sweet Talk, and Trekkers.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.